R. Pezzilli, M. Falconi, A. Zerbi, R. Casadei, L. Valli, R. Varale, et al., “Clinical and Patient-Reported Outcomes after Pancreatoduodenectomy for Different Diseases: A Follow-Up Study,” Pancreas, Vol. 40, No. 6, 2011, pp. 938-945. doi:10.1097/MPA.0b013e318216f693

has been cited by the following article:

• TITLE: Evaluation of Surgical Outcome after Resection of Pancreatic Tumors, Our Experience in Mansoura Oncology Center, a Middle-Volume Center in Egypt

  AUTHORS: Nazem Shams, Mahmoud Mosbah, Mohammad Hegazy, Osama Hussein, Omar Farouk, Sameh Roshdy, Mohamed Tarek Hafez, Ashraf Khater, Khaled Abdel Wahab

  KEYWORDS: Pancreatic Cancer; Whipple; Complication; Survival

  JOURNAL NAME: Journal of Cancer Therapy, Vol.3 No.5, October 17, 2012

  ABSTRACT: Background: Pancreatic cancer is the fourth most common cause of cancer related deaths in the world. Surgical resection remains the only potentially curative treatment for adenocarcinoma of the pancreas; only 10% - 20% of patients are candidate for standard pancreatic resection. Objective: To evaluate perioperative mortality, morbidity and survival for patients underwent PD in middle-volume center. Patients and Methods: Sixty patients with pancreatic tumors were enrolled in this study for different surgical procedure according to type of tumors. Results: No early postoperative complications were observed in 60% of patients, whereas 40% of patients developed one or more complication, the median survival for this group was 12.3 months with standard deviation 3.8 months.